Search

Your search keyword '"Levine, DA"' showing total 625 results

Search Constraints

Start Over You searched for: Author "Levine, DA" Remove constraint Author: "Levine, DA"
625 results on '"Levine, DA"'

Search Results

1. Prognostic gene expression signature for high-grade serous ovarian cancer.

2. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

3. Knowledge and Acceptability of Human Papillomavirus Vaccination and Text Message Reminders for Adolescents in Urban Emergency Departments: A Pilot Study

4. Integrated genomic analyses of ovarian carcinoma

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

7. Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer

8. Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

9. Sleep for Stroke Management and Recovery Trial (Sleep SMART): Rationale and methods

11. Shared heritability and functional enrichment across six solid cancers

12. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

13. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

14. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

15. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk

16. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

17. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

18. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

19. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

20. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

21. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival

22. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

23. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

24. Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types

25. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration

26. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

27. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer

28. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

29. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk

30. Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study

31. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

32. A targeted genetic association study of epithelial ovarian cancer susceptibility.

33. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

34. Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10

35. Tumours of the ovary. Serous Tumors

36. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

37. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

38. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

39. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

40. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

41. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

42. Genome-wide significant risk associations for mucinous ovarian carcinoma

43. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

44. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk

45. Association between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

47. Common variants at 19p13 are associated with susceptibility to ovarian cancer

48. Integrated genomic analyses of ovarian carcinoma

49. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and the Cancer Genome Atlas

50. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Catalog

Books, media, physical & digital resources